The treatment of advanced prostate cancer has evolved due to recent advances in molecular research and new drug development. Dynamic aberrations in the androgen receptor, DNA repair genes, PTEN-PI3K, and other pathways drive the behavior of advanced prostate cancer allowing a better selection of ...
Genetic testing, to identify pathogenic or likely pathogenic variants in prostate cancer, is valuable in guiding treatment decisions for men with prostate cancer and to inform cancer prevention and early detection options for their immediate blood relatives. There are various guidelines and consensus stat...
EBRT (External Beam Radiation Therapy):These X-rays destroy tumor cells by damaging their DNA. There is a brief exposure to the radiation, typically lasting several minutes. Once the prostate cancer treatment is over, there is no radiation in the patient’s body. The treatment is completely no...
Garnick discussed the early treatment of metastatic prostate cancer, total androgen blockade, and the cost of 1 year of flutamide therapy. He stated that 165 000 new cases of prostate cancer are expected to be diagnosed in the United States in 1993, with 25% of patients presenting with stage...
Tunn UW: Advanced prostate cancer treatment guidelines: European perspective. BJU Int 2004, 94 Suppl 3:6.Tunn UW: Advanced prostate cancer treatment guidelines: European perspective. BJU Int 2004, 94(Suppl 3):6.Tunn UW. Advanced prostate cancer treatment guidelines: European perspective. BJU ...
The objective of the French Urology Association Cancer Committee is to propose an update of the recommendations for the management of prostate cancer. Methods A systematic review of the literature from 2020 to 2022 was conducted by the CCAFU on the elements of therapeutic management of metastatic ...
Prostate cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Annal Oncol. 2020;31:1119–34. Article CAS Google Scholar Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7–30. Kolodziej M. Management of biochemically recurrent ...
Testing The Efficacy of a Couple-focused, Tailored eHealth Intervention for Symptom Self-Management Among Men with Prostate Cancer and Their Partners: The Study Protocol Trial registration {2a and 2b}. CT.gov ID: NCT03489057. Protocol version {3} May 28, 2020. Funding {4} National Institute ...
et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer — 2020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur. Urol. 79, 243–262 (2021). Article Google Scholar Mason, B. R. et al. Current status of MRI and PET in the NCCN guidelines ...
EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2017;71:618–29. https://doi.org/10.1016/j.eururo.2016.08.003. Article PubMed Google Scholar NICE. Prostate cancer diagnosis and management. Lancet. 2019; https:...